NEW BRIEF: Regulatory Roadblocks Hinder Development of New COVID-19 Treatments for the Immunocompromised
The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click to download the brief “Monoclonal antibodies provided benefits to vulnerable populations and six different ones were authorized to treat COVID-19,” said Dr. Wayne Winegarden, ...
NEW BRIEF: End Anti-Market Distortions in Current PBM System Would Lower Patient Costs, Increase Access to Life-Saving Drugs
SACRAMENTO – Fixing the current broken system that incentivizes pharmacy benefit managers (PBMs) to enact policies that benefit themselves and insurers at the expense of patients would lead to lower patient drug costs, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click to download the brief “The current system incentivizes PBMs to implement policies that benefit insurers and themselves, while making drugs less ...
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhD Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, there is growing evidence that the 340B program fails to achieve its primary goal. Giving discounts to entities, rather than to patients, primarily shifts resources ...
Trending Topics
Medicare
Public Option
Single Payer
Studies
Podcasts
Wayne Winegarden – The Impact of Covid-19 Restrictions
October 2, 2023
Bill Smith – Rationing Medicine
May 23, 2023
Blogs
Spending Watch
Single Payer Will Worsen California’s Healthcare System and Reduce Economic Growth
Wayne Winegarden
March 8, 2024
Read how Biden plan would hurt medical innovation
The Biden Administration Abuses Inflation to Attack Medical Innovation
Wayne Winegarden
December 19, 2023
Government health care hurts minority communities
Racial health gap is about government, not race
Sally C. Pipes
April 20, 2023
Commentary
Read the latest on the 340B Drug Pricing Program
Reforming 340B to Serve the Interests of Patients, Not Institutions
Pacific Research Institute
July 26, 2024
Read about Biden's plan to extend health insurance to DACA
Biden’s Healthcare Amnesty Solves Nothing — and at a Staggering Cost
Sally C. Pipes
July 23, 2024